All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2004-000718-37 | Double blind, double dummy, multinational, multicenter, parallel- group design clinical trial of superiority of CHF 1535 1 puff in b.i.d. regimen administered via an HFA-propellant-pMDI versus a doub... | 2005-02-17 | due-trials |
Reported results | 2004-000755-41 | A three-month, double-blind, double dummy, parallel group, controlled study comparing the efficacy and safety between 12 µg twice daily of Formoterol-HFA and 12 µg twice daily of Formoterol-DPI (Forad... | 2005-06-06 | due-trials |
Reported results | 2004-001109-81 | A randomised, controlled with placebo, double blind, double dummy, parallel group study on the therapeutic efficacy and safety of Beclomethasone dipropionate (BDP) in the treatment of patients with po... | 2007-02-12 | due-trials |
Reported results | 2004-001252-36 | DOUBLE BLIND, PARALLEL GROUP, MULTICENTRE STUDY TO EVALUATE THE EFFICACY AND TOLERABILITY OF CHF 1521 (FIXED COMBINATION OF MANIDIPINE AND DELAPRIL) VS LOSARTAN 50 MG AND HYDROCHLOROTHIAZIDE 12.5 MG I... | 2007-03-17 | due-trials |
Reported results | 2005-002195-15 | EVALUATION OF THE 24-HOUR TROUGH FEV1 FOLLOWING 7 DAYS OF DOSING WITH CHF4226 2µg ONCE DAILY. A MULTICENTER, DOUBLE-BLIND, DOUBLE-DUMMY, RANDOMISED, PARALLEL GROUP, PLACEBO AND ACTIVE (FORMOTEROL 12µg... | 2005-11-05 | due-trials |
Reported results | 2005-003693-14 | In-vivo deposition of formoterol after inhalation of a single dose of Formoterol HFA- MDI (Chiesi), and Foradil P inhalation powder (Novartis) in COPD patients. | 2006-05-12 | due-trials |
Completed, but no date, and reported results Terminated | 2005-005371-15 | A RANDOMIZED CONTROLLED STUDY TO EVALUATE THE EFFICACY OF A SUPPLEMENTAL DOSE OF CUROSURF IN PRE-TERM INFANTS ON MECHANICAL VENTILATION FOR RESPIRATORY DISTRESS SYNDROME RDS IN PREVENTING EXTUBATION... | bad-data | |
Completed, but no date, and reported results | 2005-005857-23 | DOUBLE BLIND, DOUBLE DUMMY, RANDOMISED, PARALLEL GROUP, MONOCENTRIC CLINICAL TRIAL ON THE EFFECTS OF CHF 1535 MDI OR SERETIDE DPI ON LUNG HYPERINFLATION AND EXERCISE TOLERANCE IN PATIENTS WITH COPD A... | bad-data | |
Reported results | 2006-000038-11 | EVALUATION OF THE EFFICACY, SAFETY AND TOLERABILITY OF THE CONCURRENT ADMINISTRATION OF CHF 4226 HFA pMDI AND EXTRAFINE BUDESONIDE HFA pMDI, BOTH GIVEN ONCE OR TWICE DAILY (2μg + 200μg qd or 1μg + 100... | 2007-02-28 | due-trials |
Completed, but no date, and reported results | 2006-000512-25 | DOUBLE BLIND, DOUBLE DUMMY, RANDOMISED, PARALLEL GROUP, MONOCENTRIC CLINICAL TRIAL ON THE EFFECTS OF CHF 1535 MDI OR SERETIDE DPI ON BIOLOGICAL AND FUNCTIONAL MARKERS OF SMALL AIRWAYS IN PATIENTS WITH... | bad-data | |
Reported results | 2006-000531-10 | A Randomized, Controlled, 14-Treatment Day, Multicenter Study to Determine the Optimal Efficacious and Safe Dose of CHF 4226 in a Metered Dose Inhaler in Treating Patients With Chronic Obstuctive Pulm... | 2007-06-26 | due-trials |
Reported results | 2006-000907-41 | A single dose, randomised, double blind, double dummy, placebo-controlled, three-period crossover clinical study, comparing the efficacy, safety and tolerability of Formoterol-HFA pMDI 12 microgram p... | 2006-11-29 | due-trials |
Reported results | 2006-001823-20 | A twelve-week, multicentre, double blind, randomised, parallel group, clinical study to assess the antihypertensive efficacy of delapril 15 mg b.i.d. and 30 mg b.i.d. versus lisinopril and placebo | 2007-12-13 | due-trials |
Exempt, with results | 2006-002094-46 | Single blind, randomized, crossover, repeated dose, pharmacokinetic and pharmacodynamic interaction study of CHF 4226 HFA and Extra-fine BUD HFA in asthmatic patients | not-yet-due | |
Reported results | 2006-002489-20 | A 48-WEEK, DOUBLE BLIND, DOUBLE DUMMY, RANDOMISED, MULTINATIONAL, MULTICENTRE, 3-ARM PARALLEL GROUP CLINICAL STUDY OF FIXED COMBINATION BECLOMETHASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE ADMINISTE... | 2008-08-07 | due-trials |
Reported results | 2006-002550-30 | A randomized controlled pilot study for the comparison of efficacy of bronchoalveolar lavage BAL with Curosurf in a dosage 50 mg/kg vs not treated control in adult patients affected by pulmonary con... | 2009-06-09 | due-trials |
Reported results | 2006-004105-25 | AN INTERNATIONAL, OPEN, RANDOMIZED, CONTROLLED STUDY TO EVALUATE THE EFFICACY OF COMBINING PROPHYLACTIC CUROSURF WITH EARLY NASAL CPAP VERSUS EARLY NASAL CPAP ALONE IN VERY PRETERM INFANTS AT RISK OF ... | 2008-06-09 | due-trials |
Reported results | 2006-004230-32 | EFFICACY AND SAFETY OF BECLOMETHASONE DIPROPIONATE GASTRO-RESISTANT, PROLONGED RELEASE TABLETS (CHF 1514) COMPARED WITH ORAL PREDNISONE, IN A 8-WEEK TREATMENT PERIOD, IN PATIENTS WITH ACTIVE ULCERATIV... | 2008-12-02 | due-trials |
Reported results | 2006-005349-13 | ENSAYO CLÍNICO PROSPECTIVO, ALEATORIZADO, ABIERTO, MULTICÉNTRICO, CONTROLADO CON FÁRMACO ACTIVO, DE GRUPOS PARALELOS PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE DIPROPIONATO DE BECLOMETASONA 400 µG + F... | 2010-03-29 | due-trials |
Exempt, with results | 2006-005557-30 | In-vivo deposition measurement of formoterol and beclomethasone after inhalation of a single dose of the combination Formoterol plus BDP HFA pMDI (Foster®, Chiesi) in healthy volunteers, asthmatic an... | 2007-05-04 | not-yet-due |
Reported results | 2006-005689-38 | EVALUATION OF THE EFFECT OF 4 WEEKS TREATMENT WITH CHF 4226 pMDI 2µg DOSE GIVEN ONCE DAILY IN THE EVENING ON 24-HOUR TROUGH FEV1 IN ADULT AND ADOLESCENT PATIENTS AGED 15 YEARS OR OVER WITH MODERATE OR... | 2007-10-05 | due-trials |
Reported results | 2006-006215-68 | A MULTICENTRE,MULTINATIONAL, OPEN-LABEL, RANDOMISED, PARALLEL GROUP CLINICAL TRIAL OF TOBRINEB®/ACTITOB®/ BRAMITOB® (TOBRAMYCIN SOLUTION FOR NEBULISATION, 300 MG TWICE DAILY IN 4 ML UNIT DOSE VIALS) C... | 2010-05-24 | due-trials |
Reported results | 2006-006350-10 | DOUBLE BLIND, RANDOMISED, PARALLEL GROUP, MULTICENTRE STUDY TO EVALUATE THE EFFECTS OF MANIDIPINE 20 MG VS AMLODIPINE 10 MG AND THE COMBINATION OF MANIDIPINE 10 MG PLUS DELAPRIL 30 MG VS AMLODIPINE 5 ... | 2009-02-28 | due-trials |
Listed as ongoing, but also has a completion date and reported results | 2007-000522-46 | A 12-WEEK, MULTICENTER, MULTINATIONAL, RANDOMISED, DOUBLE BLIND, DOUBLE-DUMMY (OPEN LABEL FOR THE SPACER GROUP), 3-ARM PARALLEL GROUP STUDY COMPARING THE EFFICACY AND THE SAFETY OF CHF 1535 HFA pMDI (... | 2008-05-31 | bad-data |
Reported results | 2007-000774-23 | EVALUATION OF CARDIAC SAFETY, TOLERABILITY AND EFFICACY OF CUMULATIVE DOSES OF CHF5188 pMDI (FIXED COMBINATION BUDESONIDE/CARMOTEROL 200/1 µg) COMPARED TO SAME CUMULATIVE DOSES OF CARMOTEROL pMDI AND ... | 2007-07-25 | due-trials |
Reported results | 2007-002587-99 | A 24-week, multicenter, multinational, randomized, double-blind, triple-dummy, 3-arm parallel group study comparing the efficacy and safety of CHF 1535 200/6 (beclomethasone dipropionate 200 g... | 2009-09-10 | due-trials |
Reported results | 2007-002816-25 | Multicentre, multinational, randomised, double blind, double dummy, active drug controlled, parallel group study design clinical trial of the efficacy and tolerability of beclomethasone dipropionate 2... | 2009-01-29 | due-trials |
Reported results | 2007-003412-59 | A SINGLE CENTRE DOUBLE-BLIND, RANDOMISED 3 PERIOD CROSS OVER STUDY TO COMPARE SAFETY ASSESSED BY KNEMOMETRY AND URINARY CORTISOL MEASUREMENTS OF BECLOMETHASONE DIPROPIONATE HFA pMDI 100 AND 200 µg B.I... | 2007-12-27 | due-trials |
Reported results | 2007-004345-14 | Dose response evaluation of CHF 1535 HFA pMDI in asthmatic patients using lung function, adenosine monophosphate bronchial challenge and fractional exhaled nitric oxide (FENO). Randomized, double-bl... | 2008-08-28 | due-trials |
Reported results Terminated | 2007-004377-26 | Effect of fixed combination of beclomethasone dipropionate/formoterol fumarate (BDP/FF), as reliever, upon exhaled nitric oxide in asthma. FENOMENO study (Fractional Exhaled Nitric Oxide-Multiple Expi... | 2009-10-01 | due-trials |
Reported results | 2008-000401-11 | A 12-week, multinational, randomised, double blind, double dummy, 4-arm parallel-group study comparing the efficacy and safety of CHF 1535 (fixed combination of beclomethasone dipropionate + formotero... | 2009-10-26 | due-trials |
Reported results | 2008-000905-12 | A single dose, randomized, double blind, double dummy, placebo controlled, three-period crossover clinical study, comparing the onset of relief from methacholine induced bronchoconstriction with fix... | 2009-11-09 | due-trials |
Reported results | 2008-001773-15 | A single centre, randomised, double-blind, double-dummy, placebo-and active-controlled, 3-way cross-over study to evaluate the 24 hour FEV1 profile of a single dose of CHF 5188 pMDI (400/4 mcg QD) (fi... | 2009-01-06 | due-trials |
Reported results | 2008-003740-11 | A PHASE 4, MULTINATIONAL, MULTICENTRE, DOUBLE BLIND, DOUBLE DUMMY, RANDOMIZED, PARALLEL GROUP, CONTROLLED CLINICAL STUDY OF FIXED COMBINATION BECLOMETHASONE DIPROPIONATE 100 µg PLUS FORMOTEROL FUMARAT... | 2010-09-30 | due-trials |
Reported results | 2008-004671-22 | A 48-week, multicentre, multinational, randomized, double-blind, 2-arm parallel group study, comparing the efficacy of FOSTER? for maintenance and reliever versus fixed-dose FOSTER? for maintenance + ... | 2010-12-07 | due-trials |
Reported results | 2008-004842-10 | A phase II, multinational, multicentre, double blind, double dummy, randomised, 5-way cross-over, placebo and active controlled clinical study to test the non-inferiority of a single dose of CHF 1535... | 2009-07-09 | due-trials |
Reported results | 2008-005707-26 | Effect of beclomethasone dipropionate/formoterol fumarate (BDP+FF) administered as a fixed pMDI combination on lung impedance and exhaled nitric oxide in comparison with the fixed combination of budes... | 2010-05-14 | due-trials |
Reported results | 2008-008656-16 | A Single-centre, Double-blind, Double-dummy, Randomised, Crossover Study to investigate the effect of Formoterol HFA-pMDI versus Salmeterol HFA-pMDI on small airways physiological parameters in COPD p... | 2012-09-17 | due-trials |
Exempt, with results | 2009-010267-17 | IN-VIVO DEPOSITION MEASUREMENT OF BECLOMETASONE AND FORMOTEROL AFTER INHALATION OF A SINGLE DOSE OF THE COMBINATION BDP PLUS FORMOTEROL NEXT (TM) DPI IN HEALTHY VOLUNTEERS, ASTHMATIC AND COPD PATIENTS | 2010-10-06 | not-yet-due |
Reported results | 2009-010434-22 | A SINGLE-DOSE, OPEN-LABEL, 2-WAY CROSS-OVER, CLINICAL PHARMACOLOGY STUDY OF CHF 1535 50/6 HFA pMDI (FIXED COMBINATION OF BECLOMETHASONE DIPROPIONATE 50µg PLUS FORMOTEROL FUMARATE 6 µg ) USING THE AERO... | 2010-12-07 | due-trials |
Reported results | 2009-012546-23 | A 48-WEEK, DOUBLE BLIND, RANDOMIZED, MULTINATIONAL, MULTICENTRE, 2-ARM PARALLEL GROUP, REFERENCE TREATMENT CONTROLLED CLINICAL TRIAL OF “FIXED COMBINATION” BECLOMETHASONE DIPROPIONATE PLUS FORMOTERO... | 2012-03-06 | due-trials |
Reported results | 2009-013759-32 | A RANDOMISED, DOUBLE-BLIND, ACTIVE-CONTROLLED, 3 WAY CROSS-OVER STUDY TO EVALUATE THE EFFECT ON TROUGH FEV1 AFTER 4 WEEKS TREATMENT WITH CHF 5188 pMDI QD (FIXED COMBINATION BUDESONIDE / CARMOTEROL) IN... | 2010-06-23 | due-trials |
Completed, but no date Terminated | 2009-014376-22 | MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, TWO-ARM PARALLEL GROUPS STUDY DESIGN TO DEMONSTRATE THE EFFICACY AND TOLERABILITY OF A SINGLE DOSE OF BDP SUSPENSION FOR NEBULISATION 1600 ... | bad-data | |
Reported results | 2009-014410-10 | A 12-week, multicentre, multinational, randomized, double-blind, double-dummy, 2-arm parallel group study comparing the efficacy and safety of Foster 100/6 (beclomethasone dipropionate 100 �g plus for... | 2012-04-13 | due-trials |
Trial is partly outside EEC, and reported results | 2009-016757-18 | A phase III, 12-week, multicentre, multinational, randomised, double-blind, double-dummy, 3 arm-parallel group study to test the efficacy of CHF 1535 50/6 ?g (fixed combination of beclomethasone dipro... | 2012-10-31 | bad-data |
Reported results | 2010-018668-18 | RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY TO INVESTIGATE THE BRONCHODILATOR EFFICACY AND SAFETY AFTER SINGLE AND REPEATED ADMINISTRATIONS OF DIFFERENT DOSES OF GLYCOPYRROLATE VIA ... | 2011-08-10 | due-trials |
Reported results | 2010-018947-33 | A MULTICENTER, MULTINATIONAL, SINGLE-DOSE, OPEN LABEL, RANDOMIZED, 2-WAY CROSSOVER, CLINICAL PHARMACOLOGY STUDY OF CHF 1535 100/6 NEXT DPI® (FIXED COMBINATION OF BECLOMETHASONE DIPROPIONATE 100 µg PLU... | 2011-12-17 | due-trials |
Reported results | 2010-020602-14 | A 12-WEEK, MULTINATIONAL, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, 2-ARM PARALLEL GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF CHF 1535 200/6µg (FIXED COMBINATION BECLOMETHASONE DIPROP... | 2012-11-29 | due-trials |
Reported results | 2010-022060-13 | MULTICENTRE, RANDOMIZED, OPEN-LABEL, TWO-ARM PARALLEL GROUPS, ACTIVE CONTROLLED STUDY DESIGN TO DEMONSTRATE EFFICACY AND TOLERABILITY OF CLODRONATE 200 MG/4 ML SOLUTION FOR INTRAMUSCULAR USE WITH 1% L... | 2013-03-04 | due-trials |
Reported results | 2010-022615-19 | Pilot, Open-Label, Randomised, Repeated Dose, 4-Way Cross-Over, Clinical Pharmacology Study of Beclomethasone Dipropionate (Clenil® Modulite®) 250 µg HFA PMDI using the Aerochamber Plus™ Spacer Device... | 2011-06-28 | due-trials |
Completed, but no date, and reported results Terminated | 2010-022895-30 | A 12-week, multicentre, randomised, double-blind, double-dummy, 2-arm parallel group study comparing the efficacy and safety of Foster® 100/6 (beclomethasone dipropionate 100 µg plus formoterol 6 µg/a... | bad-data | |
Reported results | 2010-023281-47 | A phase III, 8-week, multinational, multicentre, randomized, double-blind, triple-dummy, active controlled, 3-arm parallel-group clinical trial to test the efficacy of CHF 1535 (fixed combination of b... | 2011-08-29 | due-trials |
Reported results | 2010-023637-29 | A SINGLE CENTRE, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, 2-WAY CROSS OVER STUDY TO COMPARE SAFETY ASSESSED BY KNEMOMETRY AND URINARY CORTISOL MEASUREMENTS OF CHF1535 50/6 pMDI (FIXED COMBINATION OF BE... | 2014-04-29 | due-trials |
Completed, but no date | 2010-024270-19 | A Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Multiple Dose Regimens of CHF 5074 (200, 400, 600 mg/day for up to 12 Weeks) and to Explore the Effect... | bad-data | |
Reported results | 2010-024384-40 | A single-dose, open-label, randomized, 2-way crossover, clinical pharmacology study of four inhalations of CHF 1535 100/6 NEXT DPI® (fixed combination of beclomethasone dipropionate 100μg plus formote... | 2011-06-09 | due-trials |
Completed, but no date, and reported results | 2011-001208-36 | A SINGLE-DOSE, OPEN-LABEL, RANDOMIZED, 2-WAY CROSS-OVER, CLINICAL PHARMACOLOGY STUDY OF CHF 1535 50/6 NEXT DPI® (FIXED COMBINATION OF BECLOMETASONE DIPROPIONATE 50 µg PLUS FORMOTEROL FUMARATE 6 µg ) V... | bad-data | |
Exempt, with results | 2011-001331-22 | A FIRST IN HUMAN CLINICAL STUDY ON THE SAFETY AND TOLERABILITY OF TWO ESCALATING SINGLE DOSES OF CHF 5633 (SYNTHETIC SURFACTANT) IN PRETERM NEONATES WITH RESPIRATORY DISTRESS SYNDROME | 2015-01-23 | not-yet-due |
Reported results | 2011-001459-35 | MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED STUDY ON THE THERAPEUTIC EFFICACY AND SAFETY OF BECLOMETHASONE DIPROPIONATE SUSPENSION FOR INHALATION 800 micrograms TWICE DA... | 2014-04-24 | due-trials |
Trial is partly outside EEC, and reported results | 2011-002060-24 | A phase II, multinational, multicentre, double blind, double dummy, randomised, cross-over, active - and placebo-controlled clinical study to compare the bronchodilator effect of single administration... | 2013-02-19 | bad-data |
Reported results | 2011-003449-17 | A 12-week, multicenter, randomized, double-blind, double-dummy, 2-arm parallel group study comparing the efficacy and safety of Foster NEXThaler (beclomethasone dipropionate 100 µg plus formoterol 6... | 2014-10-30 | due-trials |
Reported results | 2011-003588-31 | A multicentre, randomised, double-blind, active-controlled, 4-way cross-over study to evaluate the efficacy and safety of a free combination of 3 doses of Glycopyrrolate with fixed combination Beclome... | 2012-09-28 | due-trials |
Reported results | 2011-004759-37 | RANDOMIZED, DOUBLE-BLIND, ACTIVE CONTROLLED, 3-ARM PARALLEL GROUP, MULTI-NATIONAL, MULTI-CENTRE STUDY TO EVALUATE THE CARDIAC SAFETY OF TWO DOSES OF GLYCOPYRROLATE BROMIDE (25µG AND 50µG BID) DELIVERE... | 2012-09-28 | due-trials |
Reported results | 2011-005108-14 | A single- dose, open label, randomized, 3-way crossover, clinical pharmacology study of CHF 1535 100/6 pMDI (fixed combination of beclomethazone dipropionate 100 μg plus formoterol fumarate 6 μg) wit... | 2012-08-24 | due-trials |
Completed, but no date, and reported results | 2012-000039-22 | AN OPEN LABEL PLACEBO STUDY TO ASSESS THE INHALATION PROFILE OBTAINED BY ACOUSTIC MONITORING IN ASTHMATIC PATIENTS USING THE NEXTHALER DRY POWDER INHALER (DPI) DEVICE. Studio in Aperto con Placebo ... | bad-data | |
Reported results | 2012-001005-25 | A randomised, double-blind, double-dummy, placebo and active-controlled, three-way crossover study to evaluate the safety, tolerability and efficacy of 28-day inhaled CHF 6001 DPI (1200microgrammes da... | 2013-10-21 | due-trials |
Reported results | 2012-001483-29 | A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, THREE-WAY CROSSOVER STUDY TO EVALUATE THE EFFICACY AFTER ALLERGEN CHALLENGE, SAFETY, AND TOLERABILITY OF TWO DOSES OF INHALED CHF6001 DPI AFTER 9 DAYS O... | 2013-04-10 | due-trials |
Reported results | 2012-002370-30 | A PHASE II, MONOCENTRE, OPEN, RANDOMIZED, 6-WAY CROSS-OVER CLINICAL PHARMACOLOGY STUDY TO EVALUATE THE LUNG BIOAVAILABILITY OF BDP/B17MP AND FORMOTEROL AND THE TOTAL SYSTEMIC EXPOSURE ACROSS TWO DIFFE... | 2013-01-21 | due-trials |
Reported results | 2013-000063-91 | A 52-week, Double Blind, Double dummy, Randomized, Multinational, Multicentre, 3-arm Parallel Group, active Controlled Clinical Trial of fixed combination of beclometasone dipropionate plus formoterol... | 2016-03-18 | due-trials |
Completed, but no date, and reported results | 2013-000262-11 | An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler® Dry Powder Inhaler (DPI) Device. Studio in aperto con placebo per ... | bad-data | |
Reported results | 2013-000321-31 | A multi-center, un-controlled, open-labeled trial of the long-term safety of Velmanase Alfa aftercare treatment of subjects with alpha-Mannosidosis whom previously participated in Velmanase Alfa - tri... | 2022-09-30 | due-trials |
Listed as ongoing, but also has a completion date and reported results | 2013-000336-97 | A multi-center, un-controlled, open-labeled trial of the long-term safety of Lamazym aftercare treatment of subjects with alpha-Mannosidosis | 2022-09-30 | bad-data |
Reported results | 2013-001057-27 | A 52-week, double-blind, randomized, multinational, multicentre, 2-arm parallel-group, active-controlled clinical trial of fixed combination of beclometasone dipropionate plus formoterol fumarate plus... | 2016-01-13 | due-trials |
Trial is outside EEC | 2013-001268-44 | Open label study to assess the efficacy, safety and dosing of clevidipine in pediatric patients undergoing surgery. | bad-data | |
Reported results | 2013-002966-38 | A PHASE II, PARTIAL-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 5-WAY CROSS-OVER CLINICAL PHARMACOLOGY STUDY TO EVALUATE THE PHARMACODYNAMICS OF BDP/B17MP AND FORMOTEROL ACROSS TWO DIFFERENT DOSE LEVELS OF... | 2014-04-11 | due-trials |
Reported results | 2013-003043-36 | A multicentre, randomised, double-blind, active-controlled, 3-way cross-over study to evaluate the efficacy and safety of a free combination of 3 doses of CHF 5259 (glycopyrrolate) plus Foster® 100/6µ... | 2015-03-30 | due-trials |
Reported results | 2013-004826-27 | A phase II, multicentre, double blind, randomised, 5-way cross-over study to test the non-inferiority of the acute bronchodilator effect of CHF 1535 200/6 µg NEXThaler® versus CHF 1535 100/6 µg NEXTh... | 2014-10-14 | due-trials |
Reported results | 2013-005268-25 | A MULTINATIONAL, MULTICENTRE, RANDOMISED, DOUBLE BLIND, PLACEBO-CONTROLLED , 2-WAY CROSSOVER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GLYCOPYRROLATE BROMIDE ADMINISTERED VIA PMDI (CHF 5259), FOR T... | 2015-02-06 | due-trials |
Reported results | 2014-001442-16 | A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 2-WAY CROSS-OVER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CHF 5259 (GLYCOPYRROLATE BROMIDE) pMDI ON TOP OF QVAR® pMDI FOR THE TREATMENT... | 2015-08-13 | due-trials |
Reported results | 2014-001487-35 | A Multinational, Multicentre, Randomised, Open-Label, Active-Controlled, 26-Week, 2-Arm, Parallel Group Study to Evaluate the Non-Inferiority of Fixed Combination of Beclometasone Dipropionate Plus Fo... | 2017-01-05 | due-trials |
Reported results | 2014-001704-22 | A 52-week, Double Blind, Double dummy, Randomized, Multinational, Multicentre, 2-arm Parallel Group, active Controlled Clinical Trial of fixed combination of beclometasone dipropionate plus formoterol... | 2017-07-10 | due-trials |
Listed as ongoing, but also has a completion date and reported results | 2014-002845-23 | Multinational, multicentre, prospective, open-label, uncontrolled clinical trial to assess the efficacy and safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for restoration o... | 2022-03-11 | bad-data |
Reported results | 2014-004314-29 | MULTICENTRE, OPEN LABEL, RANDOMIZED, TWO-ARM, PARALLEL-GROUP STUDY TO ASSESS EFFICACY AND SAFETY OF ENVARSUS® COMPARED WITH TACROLIMUS USED AS PER CURRENT CLINICAL PRACTICE IN THE INITIAL MAINTENANCE ... | 2017-01-24 | due-trials |
Reported results | 2014-005572-28 | Open-label, Multicentre, Randomized Clinical Trial To Compare The Pharmacokinetics Of Envarsus® Tablets And Advagraf® Capsules Administered Once Daily In Adult De-novo Kidney Transplant Patients Et... | 2016-06-24 | due-trials |
Reported results | 2015-000558-40 | A multicenter, randomised, double blind, placebo-controlled, incomplete block, 3-way cross-over study to evaluate the efficacy and safety of 4 doses of glycopyrronium bromide DPI in moderate to severe... | 2017-02-06 | due-trials |
Reported results | 2015-000716-18 | A 52 week, randomized, double blind, multinational, multicentre, active controlled, 2-arm parallel group trial comparing CHF 5993 100/6/12.5 µg pMDI (fixed combination of extrafine beclometasone dipro... | 2018-05-17 | due-trials |
Reported results | 2015-000717-40 | A 52 week, randomized, double blind, multinational, multicentre, active controlled, 3-arm parallel group trial comparing CHF 5993 200/6/12.5 µg pMDI (fixed combination of extrafine beclometasone dipro... | 2018-05-28 | due-trials |
Listed as ongoing, but also has a completion date and reported results | 2015-001344-11 | Multinational, multicenter, prospective, long-term safety and efficacy follow-up study after Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for restoration of corneal epithelium in p... | 2023-03-31 | bad-data |
Reported results | 2015-005152-10 | A SINGLE-DOSE, OPEN-LABEL, RANDOMIZED, 2-WAY CROSS-OVER, CLINICAL PHARMACOLOGY STUDY OF CHF 1535 35/4 NEXTHALER® (DPI FIXED COMBINATION OF BECLOMETASONE DIPROPIONATE (BDP) 35 µg PLUS FORMOTEROL FUMARA... | 2017-06-08 | due-trials |
Reported results | 2015-005548-32 | A 24-WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO AND ACTIVE CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF 4 DOSES OF CHF 6001 DPI IN PATI... | 2018-01-09 | due-trials |
Reported results | 2015-005550-35 | A RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED, REPEATED DOSE, THREE-WAY CROSSOVER STUDY TO EVALUATE THE PHARMACODYNAMICS, PHARMACOKINETICS AND SAFETY OF TWO DOSES OF CHF 6001 DPI IN SUBJECTS WITH MOD... | 2018-12-28 | due-trials |
Exempt, with results | 2015-005551-27 | A First in Human Randomised, Double-Blind, Placebo-Controlled Study of Single Ascending Doses in Healthy Male Volunteers and Repeated Ascending Dose in Asthmatic Patients Followed by a 3-Way Cross-Ove... | 2019-04-18 | not-yet-due |
Completed, but no date, and reported results | 2015-005640-34 | Envarsus® tablets administered once daily in combination with everolimus in elderly de-novo kidney transplant recipients: open-label, multicentre, single-arm, pharmacokinetic and clinical study EN... | bad-data | |
Trial is outside EEC, and reported results | 2016-000134-22 | A Prospective, Open-Label, Single-Arm, Multi-Center Study to Assess The Pharmacokinetics/Pharmacodynamics (PK/PD) AND Safety Of Different Cangrelor Doses In Neonatal Subjects At Risk Of Thrombosis. | bad-data | |
Trial is outside EEC, and reported results | 2016-001974-14 | An Open-Label, Multicenter, Randomized, Controlled Study in Spontaneously Breathing Preterm Neonates with Respiratory Distress Syndrome to Compare Two Procedures for Porcine Surfactant (poractant alfa... | bad-data | |
Reported results | 2016-001988-36 | A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated velmanase alfa (recombinant human alpha-mannosidase) Treatment in Pediatric Patients below 6 years o... | 2020-07-03 | due-trials |
Reported results | 2016-003672-47 | A single dose, randomised, double blind, double dummy, placebo controlled, 3-way crossover clinical study, comparing the onset of relief from methacholine-induced bronchoconstriction with CHF1535 100/... | 2017-09-19 | due-trials |
Reported results Terminated | 2016-004547-36 | A RANDOMIZED, OPEN, MULTINATIONAL, MULTICENTRE, 2-PART STUDY IN SPONTANEOUSLY BREATHING PRETERM NEONATES WITH MILD TO MODERATE RESPIRATORY DISTRESS SYNDROME TO INVESTIGATE THE SAFETY, TOLERABILITY AND... | 2020-05-05 | due-trials |
Ongoing, reported early | 2017-000330-61 | Effect of Beclometasone dipropionate (BDP) on faecal Calprotectin levels in patients with clinically inactive Ulcerative Colitis at risk of relapse. BeCalCU study Efecto del dipropionato de beclome... | not-yet-due | |
Reported results | 2017-000438-79 | Open label, prospective, exploratory study to investigate the effect of inhaled CHF5993 pMDI on central and peripheral airway dimensions in COPD patients by Functional Respiratory Imaging | 2019-09-13 | due-trials |
Reported results | 2017-004405-41 | A phase II, multicentre, randomised, double-blind, double-dummy, active-controlled, 3-way cross-over study to evaluate the efficacy of CHF 5993 administered via Dry Powder Inhaler (DPI) versus CHF 599... | 2019-03-06 | due-trials |
Other | 2018-000353-50 | Comparison of two formulations of beclometasone/formoterol pMDI on respiratory system impedance using impulse oscillometry in asthmatic patients. | not-yet-due | |
Ongoing | 2018-001148-67 | Open Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegunigalsidase Alfa (PRX-102) in Patients With Fabry Disease | not-yet-due | |
Exempt, with results | 2018-001724-19 | A randomised, double-blind, placebo-controlled study to investigate the safety, tolerability, pharmacokinetic and pharmacodynamic profiles of CHF6467 after single and repeated ascending doses in subje... | 2021-01-07 | not-yet-due |
Other | 2018-001947-30 | Open Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegunigalsidase Alfa (PRX-102) 2 mg/kg Administered by Intravenous Infusion Every 4 Weeks in Patients with Fabry Disease | not-yet-due | |
Listed as ongoing, but also has a completion date and reported results | 2018-003548-22 | A 52 week, randomised, double blind, multinational, multicentre, 4-arm parallel group trial to assess the efficacy and safety of 3 doses of CHF 6532 (10, 25 or 50 mg BID) compared to placebo on top of... | 2021-02-01 | bad-data |
Listed as ongoing, but also has a completion date and reported results | 2019-002124-32 | READY 1: A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the use of CUSA-081 for Dysfunctional Central Venous Access Devices (CVADs) | 2023-07-10 | bad-data |
Reported results | 2019-002238-35 | A SINGLE-DOSE, UNCONTROLLED, OPEN LABEL, NON-RANDOMIZED, CLINICAL PHARMACOLOGY STUDY OF CHF 5993 100/6/12.5 μg PMDI (FIXED COMBINATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE PLUS GLYCO... | 2021-02-04 | due-trials |
Other | 2019-002744-24 | A phase IV, open label, multicentre, randomised, 2-way cross-over exploratory clinical trial comparing a fixed combination of beclometasone dipropionate plus formoterol fumarate plus glycopyrronium ad... | not-yet-due | |
Reported results | 2020-002356-20 | Open label, prospective study to evaluate the effect of step-up from non-extrafine ICS/LABA DPI to extra fine triple therapy with CHF5993 DPI on airway geometry and lung ventilation using FRI in subje... | 2022-01-03 | due-trials |
Other | 2020-002389-16 | A phase III, 52-week, multinational, multicenter, randomized, double-blind, 2-arm parallel group study comparing efficacy, safety and tolerability of the fixed dose triple combination of beclomethason... | not-yet-due | |
Listed as ongoing, but also has a completion date and reported results | 2020-002632-75 | COVID-19- Multicenter, open-label, randomised trial to assess the efficacy and tolerability of poractant alfa (porcine surfactant, Curosurf®) in hospitalized patients with SARS-COV-19 acute respirator... | 2022-03-18 | bad-data |
Other | 2020-003648-97 | A 52-week, randomized, double-blind, double-dummy, placebo- and active- controlled (Roflumilast, Daliresp® 500μg), parallel group, study to evaluate the efficacy and safety of two doses of CHF6001 DPI... | not-yet-due | |
Other | 2020-003666-40 | A 52-week, randomized, double-blind, placebo-controlled, parallel-group, study to evaluate the efficacy and safety of two doses of CHF6001 DPI add-on to maintenance triple therapy in subjects with Chr... | not-yet-due | |
Listed as ongoing, but also has a completion date and reported results | 2020-004718-36 | A Double Blind, Multicentre, Randomised, Placebo-Controlled, 3-Way Cross-Over Study To Evaluate The Effect Of A Triple Combination Of Beclometasone Dipropionate And Formoterol Fumarate Plus Glycopyrro... | 2023-02-24 | bad-data |
Ongoing, reported early | 2021-001449-11 | An exploratory, double-blind, randomised, multicenter, psychopharmacological study in adult patients with moderate to severe asthma to compare two pressurised Metered-Dose Inhalers (pMDIs) on patients... | not-yet-due | |
Listed as ongoing, but also has a completion date | 2021-002391-39 | A 26 WEEK, RANDOMIZED, DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, ACTIVE CONTROLLED, 2-ARM PARALLEL GROUP TRIAL COMPARING CHF 5993 100/6/12.5 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECL... | 2024-04-16 | bad-data |
Reported results Terminated | 2021-004026-30 | READY 2: A PHASE 3, OPEN LABEL, SINGLE ARM STUDY ON THE USE OF CUSA-081 FOR DYSFUNCTIONAL CENTRAL VENOUS ACCESS DEVICES (CVADs) | 2022-03-22 | due-trials |